Rajesh Kumar
Stock Analyst at HSBC
(3.36)
# 857
Out of 4,820 analysts
20
Total ratings
61.54%
Success rate
14.09%
Average return
Main Sectors:
Stocks Rated by Rajesh Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IQV IQVIA Holdings | Downgrades: Hold | $260 → $160 | $150.28 | +6.47% | 1 | Apr 25, 2025 | |
| KDP Keurig Dr Pepper | Upgrades: Buy | $36 → $42 | $34.40 | +22.09% | 1 | Apr 25, 2025 | |
| ABBV AbbVie | Upgrades: Buy | $185 | $186.06 | -0.57% | 3 | Jun 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $660 → $670 | $424.24 | +57.93% | 3 | Apr 30, 2024 | |
| DHR Danaher | Upgrades: Buy | $250 → $280 | $197.14 | +42.03% | 2 | Apr 17, 2024 | |
| UNH UnitedHealth Group | Upgrades: Hold | $460 | $418.64 | +9.88% | 2 | Apr 4, 2024 | |
| TEVA Teva Pharmaceutical Industries | Initiates: Buy | $13 | $14.87 | -12.58% | 1 | Dec 18, 2023 | |
| BMY Bristol-Myers Squibb Company | Upgrades: Hold | $55 → $53 | $47.90 | +10.65% | 2 | Oct 27, 2023 | |
| MRNA Moderna | Initiates: Reduce | $97 | $27.22 | +256.36% | 1 | Jul 14, 2023 | |
| BNTX BioNTech SE | Initiates: Buy | $124 | $102.02 | +21.54% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $22.92 | +118.15% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $123 | $82.74 | +48.66% | 1 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $560 | $884.54 | -36.69% | 1 | Jul 14, 2023 |
IQVIA Holdings
Apr 25, 2025
Downgrades: Hold
Price Target: $260 → $160
Current: $150.28
Upside: +6.47%
Keurig Dr Pepper
Apr 25, 2025
Upgrades: Buy
Price Target: $36 → $42
Current: $34.40
Upside: +22.09%
AbbVie
Jun 5, 2024
Upgrades: Buy
Price Target: $185
Current: $186.06
Upside: -0.57%
Thermo Fisher Scientific
Apr 30, 2024
Maintains: Buy
Price Target: $660 → $670
Current: $424.24
Upside: +57.93%
Danaher
Apr 17, 2024
Upgrades: Buy
Price Target: $250 → $280
Current: $197.14
Upside: +42.03%
UnitedHealth Group
Apr 4, 2024
Upgrades: Hold
Price Target: $460
Current: $418.64
Upside: +9.88%
Teva Pharmaceutical Industries
Dec 18, 2023
Initiates: Buy
Price Target: $13
Current: $14.87
Upside: -12.58%
Bristol-Myers Squibb Company
Oct 27, 2023
Upgrades: Hold
Price Target: $55 → $53
Current: $47.90
Upside: +10.65%
Moderna
Jul 14, 2023
Initiates: Reduce
Price Target: $97
Current: $27.22
Upside: +256.36%
BioNTech SE
Jul 14, 2023
Initiates: Buy
Price Target: $124
Current: $102.02
Upside: +21.54%
Jul 14, 2023
Initiates: Buy
Price Target: $50
Current: $22.92
Upside: +118.15%
Jul 14, 2023
Initiates: Hold
Price Target: $123
Current: $82.74
Upside: +48.66%
Jul 14, 2023
Initiates: Buy
Price Target: $560
Current: $884.54
Upside: -36.69%